DDIT3 Back

DNA-damage-inducible transcript 3

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of DDIT3
This gene encodes a member of the CCAAT/enhancer-binding protein (C/EBP) family of transcription factors. The protein functions as a dominant-negative inhibitor by forming heterodimers with other C/EBP members, such as C/EBP and LAP (liver activator protein), and preventing their DNA binding activity. The protein is implicated in adipogenesis and erythropoiesis, is activated by endoplasmic reticulum stress, and promotes apoptosis. Fusion of this gene and FUS on chromosome 16 or EWSR1 on chromosome 22 induced by translocation generates chimeric proteins in myxoid liposarcomas or Ewing sarcoma. Multiple alternatively spliced transcript variants encoding two isoforms with different length have been identified.

Community Annotation of DDIT3 Add / Edit DDIT3: Annotations

No community annotations yet for DDIT3.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

DDIT3 is highly significantly mutated in
(none)
DDIT3 is significantly mutated in
(none)
DDIT3 is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for DDIT3